Rimegepant 75 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 75 mg

Reference Brands: Nurtec ODT (USA), Vydura (EU)

Category: Neurology

Rimegepant 75 mg orally disintegrating tablets are a CGRP receptor blocker that both treats migraine attacks and prevents migraine when taken every other day. It does not narrow blood vessels, so it can be used by people who cannot take triptans. It is made by Pfizer as Nurtec ODT (US) and Vydura (EU). Supply is through authorised distribution or named-patient import; ask us which route fits your country.

Product Description:

Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist used for both the acute treatment of migraine attacks with or without aura and the preventive treatment of episodic migraine in adults. Unlike conventional pain relievers, rimegepant is specifically designed to target the underlying mechanism of migraine rather than providing general pain relief. It is particularly beneficial for patients whose migraine symptoms are not adequately controlled with common analgesics such as acetaminophen, aspirin, or non-steroidal anti-inflammatory drugs.

Rimegepant is marketed under the brand name Nurtec ODT and is formulated as an orally disintegrating tablet, allowing it to dissolve on or under the tongue without the need for water. This convenient dosage form makes it suitable for use during migraine attacks, especially when nausea or vomiting is present. The drug works by selectively blocking CGRP receptors, which play a key role in migraine pathophysiology by mediating pain transmission and inflammation in the nervous system.

By inhibiting CGRP activity, rimegepant helps reduce migraine pain, associated symptoms, and attack frequency when used preventively. It does not cause vasoconstriction, making it an important therapeutic option for patients who may not tolerate or are contraindicated for triptan therapy.